- Filed
- Feb 26, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $223.1M |
| Current Liabilities restated | FY 2024 · Dec 31, 2023 | $342.35M |
| Total Liabilities restated | FY 2024 · Dec 31, 2023 | $764.91M |
| Current Assets restated | FY 2024 · Dec 31, 2023 | $509.3M |
| Total Assets restated | FY 2024 · Dec 31, 2023 | $1.11B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 139.61M sh |
| Capex restated | FY 2024 · Dec 31, 2022 | $55.67M |
| Operating Cash Flow restated | FY 2024 · Dec 31, 2022 | $77.46M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | $0.98 |
| Eps Basic | FY 2024 · Dec 31, 2022 | $0.99 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $340.39M |
| Net Income | FY 2024 · Dec 31, 2022 | $136.63M |
| Operating Income | FY 2024 · Dec 31, 2022 | $184.67M |
| Gross Profit | FY 2024 · Dec 31, 2022 | $525.06M |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $703.87M |
| Revenue | FY 2024 · Dec 31, 2022 | $1.23B |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $69.77M |